Navigation Links
LeMaitre Vascular, Inc. Schedules First Quarter Results and Conference Call
Date:4/18/2008

BURLINGTON, Mass., April 18 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that it will release its 2008 first quarter financial results on April 30, 2008, after the close of the market. In conjunction with the release, a conference call will be hosted the same day at 5:00 PM ET. The call will be broadcast simultaneously over the internet.

Interested participants may listen to the live webcast at http://www.lemaitre.com/investor, or dial in at 866-831-6247 (+1 617-213-8856 for international callers), using passcode 22576785. A replay of the call will be available at http://www.lemaitre.com/investor .

During the call, LeMaitre's senior management will provide an overview of the first quarter results, business highlights and company outlook.

About LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease. The Company's principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803. Additional information can be found at http://www.lemaitre.com .


'/>"/>
SOURCE LeMaitre Vascular, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. LeMaitre Vascular Announces Changes to Its Executive Management Team
2. LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase
3. LeMaitre Vascular, Inc. Schedules Fourth Quarter Results and Conference Call
4. LeMaitre Vascular Launches Next-Generation Stent Graft Delivery System
5. LeMaitre Vascular to Participate at Canaccord Adams Inaugural Cardiovascular Conference
6. LeMaitre Vascular Reports Q3 2007 Revenue of $10.1 Million, a 19% Increase
7. LeMaitre Vascular to Participate at CIBC 18th Annual Healthcare Conference
8. LeMaitre Vascular to Start Italian Sales Force
9. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 24, 2008 to Discuss First Quarter 2008 Results
10. MSA Schedules First Quarter Earnings Webcast
11. Omnicell Schedules First Quarter 2008 Earnings Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... , ... February 20, 2017 , ... ... offering a full range of emergency dental care at his office, Antoine Dental ... When patients experience dental emergencies, they are at risk for serious complications and ...
(Date:2/20/2017)... FL (PRWEB) , ... February 20, 2017 , ... ... gift from Constellation Brands to purchase a new ultrasound-enhanced thrombolysis machine, a state-of-the-art ... waves. The gift was facilitated by the Pepin Family Foundation. , “We greatly ...
(Date:2/19/2017)... ... February 19, 2017 , ... "At your fingertips" electronic access ... and the Delaware Health Information Network (DHIN) have partnered to improve connectivity of ... health information exchange, DHIN stores and shares real-time health data for more than ...
(Date:2/18/2017)... ... February 17, 2017 , ... Butler Mobility invited Ken Matthews to visit ... Butler products. Ken was impressed with the safety and reliability of the Stannah ... on his show. This endorsement by Ken Matthews can be heard on News ...
(Date:2/18/2017)... MANDEVILLE, La. (PRWEB) , ... February 18, 2017 ... ... Network released today provides the latest information and contact points to easily connect ... including home care, assisted living, and elder-care funding. It also conveys material on ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, ... technologies market is expected to grow at a CAGR of 9.4% ... expected to grow at a CAGR of 9.5% from 2017 to ... in 2026. ... this report will benefit you Read on to discover how ...
(Date:2/17/2017)... Feb. 17, 2017 Theravance Biopharma, Inc. ... the "Company") today announced the presentation of positive ... orally administered pan-Janus kinase (JAK) inhibitor designed to ... Congress of the European Crohn,s and Colitis Organization ... further data from its completed Phase 1 study ...
(Date:2/17/2017)... 2017   Risperdal lawsuits involving gynecomastia (male breast ... use of the atypical antipsychotic medication continue to move ... of Common Pleas, where the state,s Risperdal docket has ... a notice posted on the Court,s website , ... March 9, 2017 at 11:00 a.m. (In Re: Risperdal ...
Breaking Medicine Technology: